EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC-ND 4.0

Container Closure Integrity of a Glass Prefillable Syringe in Deep Frozen Storage Conditions

Jessica Baseggio, Anton Zverev, Odra Pinato, Anthony Vico, Jason E Fernandez, Satish K Singh

Journal of Pharmaceutical Sciences · 2024

DOI: 10.1016/j.xphs.2023.11.033 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of Pharmaceutical Sciences, 2024. Verfasst von Jessica Baseggio und 5 weiteren Autor:innen. Beteiligte Einrichtung: EMEA Technology Excellence Center, Stevanato Group, Piombino Dese, Italy. Hauptthemen laut MEDLINE: Drug Packaging, Syringes. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 31 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Development of novel pharmaceutical drug modalities has created a need for frozen storage and transportation. Accurate and easy assessment of container closure integrity (CCI) in frozen conditions remains a challenge. Thus, container closure systems (CCS) suitable for low temperatures have been primarily restricted to vials despite the growing popularity of prefillable syringes (PFS) for parenteral administration. A new dye ingress test method, suitable for testing at low temperatures, was developed and applied to PFS across a range of deep-frozen temperatures. The method is versatile and can easily be extended to other common CCS formats over a wide range of temperatures including storage on dry ice (-80 °C). This new method was paired with an orthogonal technique, laser-based CO2 headspace gas analysis, to evaluate the CCI of a glass PFS at temperatures from -50 °C to -80 °C. Both test methods showed comparable results and consistent CCI failure below a temperature of -70 °C. The primary mode of failure was the plunger-to-barrel interface, likely attributable to dimensional changes and loss of elasticity. This study demonstrates the temperature dependent CCI behavior of glass PFS and underscores the importance of thorough characterization of package integrity for deep frozen drug products.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Drug PackagingSyringesDrug StorageCold TemperatureFreezingGlass

Stichwörter der Autor:innen

Container closure integrityDeep frozen storageDye ingressFrozen drug productPrefillable syringePrimary packaging

Autor:innen und Institutionen

  • EMEA Technology Excellence Center, Stevanato Group, Piombino Dese, Italy.
  • Moderna, Inc., Cambridge, MA, United States of America. Electronic address: anton.zverev@modernatx.com.
  • US Technology Excellence Center, Stevanato Group, Boston, MA, United States of America.
  • Moderna, Inc., Cambridge, MA, United States of America.

Zitieren

APA

Baseggio, J., Zverev, A., Pinato, O., Vico, A., Fernandez, J. E., & Singh, S. K. (2024). Container Closure Integrity of a Glass Prefillable Syringe in Deep Frozen Storage Conditions. Journal of Pharmaceutical Sciences. https://doi.org/10.1016/j.xphs.2023.11.033

Vancouver

Baseggio J, Zverev A, Pinato O, Vico A, Fernandez JE, Singh SK. Container Closure Integrity of a Glass Prefillable Syringe in Deep Frozen Storage Conditions. Journal of Pharmaceutical Sciences. 2024. doi:10.1016/j.xphs.2023.11.033

BibTeX
@article{Baseggio2024,
  author = {Baseggio, Jessica and Zverev, Anton and Pinato, Odra and Vico, Anthony and Fernandez, Jason E and Singh, Satish K},
  title = {Container Closure Integrity of a Glass Prefillable Syringe in Deep Frozen Storage Conditions},
  journal = {Journal of Pharmaceutical Sciences},
  year = {2024},
  doi = {10.1016/j.xphs.2023.11.033}
}
Kostenlos starten →